HTC-867

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Healthy SubjectsSchizophrenia

Phase 1

Study Evaluating HTC-867 in Healthy Young and Elderly Subjects

TerminatedNCT00827489

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2009-01-31End: 2009-04-30Target: 72Updated: 2009-09-02

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

CompletedNCT01268124

Wyeth is now a wholly owned subsidiary of PfizerSchizophrenia

Start: 2008-12-31End: 2009-04-30Updated: 2010-12-29